Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FC034
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $12,467 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc., on January 19, 2026, with an ultimate completion date of January 20, 2026. This non-set-aside competitive award was issued under the Pharmaceutical Prime Vendor Global Program contract vehicle and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, delivers a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems.
This delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, an IDC valued at $999,999,999 through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains to support military healthcare programs worldwide. The DLA Troop Support Medical division is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple awards for separate regions, positioning AmerisourceBergen to continue serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract structure.
Quick answers
Who was awarded contract SPE2DU26FC034?
SPE2DU26FC034 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 19, 2026.
How much is contract SPE2DU26FC034 worth?
The government has obligated $12,467 on SPE2DU26FC034.
Is contract SPE2DU26FC034 an order under another contract?
Yes. SPE2DU26FC034 is a delivery order under SPE2DU25D4211, an indefinite delivery contract.
Was contract SPE2DU26FC034 competed?
The extent of competition for SPE2DU26FC034 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award